Richard Haynes

14PUBLICATIONS
68CO-AUTHORS
Groundwater quality processes and contaminated land assessmentEpidemiological methodsMajor global burdens of diseaseMolecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 03, 2026
Predictive Value of Urine Tubular Biomarkers on Kidney Outcomes: Observations from EMPA-KIDNEY.

|Sep 17, 2025
Blood Pressure and Mortality in Mexico City: A Mendelian Randomization Study.

Michael Turner, Pablo Kuri-Morales, Jesús Alegre-Díaz

|Apr 03, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Feb 05, 2025
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.

Doreen Zhu, Parminder K Judge, Natalie Staplin

|Nov 12, 2024
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.

Parminder K Judge, Katherine R Tuttle, Natalie Staplin

|Sep 15, 2024
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

Pageof 3

Frequent Collaborators

9 joint publications

William G Herrington

7 joint publications

Natalie Staplin

6 joint publications

Christoph Wanner

5 joint publications

Jonathan R Emberson